BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24333010)

  • 21. Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways.
    Ko HH; Chiang YC; Tsai MH; Liang CJ; Hsu LF; Li SY; Wang MC; Yen FL; Lee CW
    J Ethnopharmacol; 2014; 151(1):386-93. PubMed ID: 24212072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanogenesis inhibitory activity of sesquiterpenes from Canarium ovatum resin in mouse B16 melanoma cells.
    Kikuchi T; Watanabe K; Tochigi Y; Yamamoto A; Fukatsu M; Ezaki Y; Tanaka R; Akihisa T
    Chem Biodivers; 2012 Aug; 9(8):1500-7. PubMed ID: 22899610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
    Xiao L; Matsubayashi K; Miwa N
    Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
    J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acanthoic acid inhibits melanogenesis through tyrosinase downregulation and melanogenic gene expression in B16 melanoma cells.
    Yoon WJ; Ham YM; Yoon HS; Lee WJ; Lee NH; Hyun CG
    Nat Prod Commun; 2013 Oct; 8(10):1359-62. PubMed ID: 24354173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetramethylpyrazine inhibits production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling pathways, and suppression of intracellular reactive oxygen species.
    Liu HT; Du YG; He JL; Chen WJ; Li WM; Yang Z; Wang YX; Yu C
    J Ethnopharmacol; 2010 Jun; 129(3):335-43. PubMed ID: 20371283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galvanic zinc-copper microparticles inhibit melanogenesis via multiple pigmentary pathways.
    Won YK; Lin CB; Seiberg M; Chen N; Hu Y; Rossetti D; Saliou C; Loy CJ
    Arch Dermatol Res; 2014 Jan; 306(1):27-35. PubMed ID: 23700242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mangosteen leaf extract increases melanogenesis in B16F1 melanoma cells by stimulating tyrosinase activity in vitro and by up-regulating tyrosinase gene expression.
    Hamid MA; Sarmidi MR; Park CS
    Int J Mol Med; 2012 Feb; 29(2):209-17. PubMed ID: 22089762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fermented Viola mandshurica inhibits melanogenesis in B16 melanoma cells.
    Kwak YJ; Kim KS; Kim KM; Yu HY; Chung E; Kim SJ; Cha JY; Lee YC; Lee JH
    Biosci Biotechnol Biochem; 2011; 75(5):841-7. PubMed ID: 21597199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells.
    Lu F; Yan D; Zhou X; Hu DN; Qu J
    Mol Vis; 2007 Nov; 13():2066-72. PubMed ID: 18079680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of proanthocyanidin on ultraviolet B irradiation-induced melanogenesis.
    Cho HS; Kwak DH; Choi IS; Park HK; Kang SJ; Yoo HS; Lee MS; Oh KW; Hong JT
    J Toxicol Environ Health A; 2009; 72(21-22):1475-83. PubMed ID: 20077221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases.
    Kumar KJ; Vani MG; Wang SY; Liao JW; Hsu LS; Yang HL; Hseu YC
    Biofactors; 2013; 39(3):259-70. PubMed ID: 23322673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of whisky congeners on melanogenesis in mouse B16 melanoma cells.
    Ohguchi K; Koike M; Suwa Y; Koshimizu S; Mizutani Y; Nozawa Y; Akao Y
    Biosci Biotechnol Biochem; 2008 Apr; 72(4):1107-10. PubMed ID: 18391453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.
    Thanigaimalai P; Lee KC; Sharma VK; Joo C; Cho WJ; Roh E; Kim Y; Jung SH
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6824-8. PubMed ID: 21978680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of cytokine and nitric oxide production by keratinocytes, epithelial cells, and mononuclear phagocytes in a co-culture model of inflammatory acne.
    Watson MK; E Y; Dapul G; Lee WL; Shalita AR; Nowakowski M
    J Drugs Dermatol; 2012 Jul; 11(7):834-6. PubMed ID: 22777225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes.
    Villareal MO; Han J; Yamada P; Shigemori H; Isoda H
    Exp Dermatol; 2010 May; 19(5):450-7. PubMed ID: 19765058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone morphogenetic proteins differentially regulate pigmentation in human skin cells.
    Singh SK; Abbas WA; Tobin DJ
    J Cell Sci; 2012 Sep; 125(Pt 18):4306-19. PubMed ID: 22641693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid.
    Panich U; Onkoksoong T; Limsaengurai S; Akarasereenont P; Wongkajornsilp A
    J Photochem Photobiol B; 2012 Mar; 108():16-22. PubMed ID: 22244344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
    Englaro W; Bahadoran P; Bertolotto C; BuscĂ  R; DĂ©rijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
    Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.